Milken Institute Conferences & Summits
Partnering For Cures 2015
- Margaret Anderson - Executive Director, FasterCures
- Christopher Austin - Director, National Center for Advancing Translational Sciences, National Institutes of Health
- Linda Avey - Co-Founder & CEO, We Are Curious, Inc.
- Shiva Ayyadurai - Chairman & CEO, CytoSolve, Inc.
- LeeAnn Bailey - Specialist Leader, Deloitte Consulting LLP
- Dana Ball - Executive Director and Co-Founder, T1D Exchange; CEO, Unitio, Inc.
- Alph Bingham - Founder and Board Member, Innocentive
- Keith Black - Chairman and Professor, Department of Neurosurgery; Director, Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center
- John F. P. Bridges - Associate Professor, Center for Health Services and Outcomes Research, Johns Hopkins Bloomberg School of Public Health
- Kyle Brown - CEO and Founder, PatientCrossroads
- Nancy Brown - CEO, American Heart Association
- Kenneth Buetow - Director, Computational Science and Informatics Core Program, Complex Adaptive Systems Initiative, Arizona State University
- Robert Califf - Deputy Commissioner, Medical Products and Tobacco, U.S. Food and Drug Administration
- Stacey Chang - Executive Director, Design Institute for Health, Dell Medical School & College of Fine Arts, University of Texas at Austin
- Tony Coles - Chairman and CEO, Yumanity Therapeutics
- Francis Collins - Director, National Institutes of Health
- Louis DeGennaro - President and CEO, Leukemia & Lymphoma Society
- Stephanie Devaney - Project Manager, Precision Medicine Initiative, White House Office of Chief of Staff
- Brian Druker - Director, Oregon Health and Science University Knight Cancer Institute; JELD-WEN Chair of Leukemia Research; Investigator, Howard Hughes Medical Institute
- Mary Dwight - Senior Vice President, Policy and Community Affairs, Cystic Fibrosis Foundation
- Andrea Ferris - President and Chairman, LUNGevity Foundation
- Stephen Friend - President, Sage Bionetworks
- Kathi Hanna - Senior Fellow, FasterCures
- Paul Hastings - Chairman and CEO, OncoMed Pharmaceuticals
- Ben Heywood - Co-Founder and President, PatientsLikeMe
- Kenneth Hobby - President, Cure SMA
- Max Hodak - Co-Founder, Transcriptic
- Leah McCormick Howard - Vice President, Government Relations & Advocacy, National Psoriasis Foundation
- Clifford Hudis - Vice President for Government Relations and Chief Advocacy Officer; Chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center
- Kathy Hudson - Deputy Director for Science, Outreach, and Policy, National Institutes of Health
- Annie Kennedy - Senior Vice President, Legislation & Public Policy, Parent Project Muscular Dystrophy
- Isaac Kohane - Professor of Pediatrics and Health Sciences Technology, Harvard Medical School
- Debra Lappin - Principal, FaegreBD Consulting
- Corinna Lathan - Founder and CEO, AnthroTronix
- Teri Lawver - Global Commercial Strategy Leader, Global Vice President, Cardiovascular and Metabolism, Janssen
- Pablo Legorreta - Founder and CEO, Royalty Pharma
- Bennett Levitan - Senior Director, Benefit-Risk Assessment, Janssen
- C. Jimmy Lin - Founder & President, Rare Genomics Institute
- Peter Margolis - Professor of Pediatrics and Director of Research, James M. Anderson Center for Health System Excellence, Cincinnati Children's Hospital Medical Center
- Katherine Maynard - Principal, PWR
- Kim McCleary - Managing Director, FasterCures
- Cindy McDonald-Everett - Executive Director and Oncology TA Head, Global Pricing & Payer Planning, Amgen
- Nancy McGee - Executive Vice President, Avalere Health
- Beth Meagher - Principal, Deloitte Consulting LLP
- Michael Milken - Chairman, Milken Institute; Founder, FasterCures
- Plavi Mittal - President and CEO, Jain Foundation
- Kimberly Myers - Senior Manager, Deloitte Consulting LLP
- Sridaran Natesan - Vice President, Strategic Initiatives & Science Relations (North America), Sanofi
- Megan O'Boyle - Principal Investigator, Phelan-McDermid Syndrome International Registry; Principal Investigator, PMS Data Network, PCORnet PPRN
- J. Marc Overhage - J. Marc Overhage
- Bray Patrick-Lake - Director, Stakeholder Engagement, Clinical Trials Transformation Initiative, Duke University; Co-Chair, NIH Advisory Committee to the Director Working Group, Precision Medicine Initiative; Senior Fellow, FasterCures
- Jessica Polka - Postdoctoral Research Fellow, Silver Lab, Department of Systems Biology, Harvard Medical School
- Richard Pops - Chairman and CEO, Alkermes
- Rajesh Ranganathan - Vice President of Science and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
- Michael Rosenblatt - Executive Vice President and Chief Medical Officer, Merck & Co., Inc.
- cc - U.S. Partner, Pontifax
- Roslyn Schneider - Global Patient Affairs Lead, Pfizer Medical, Pfizer
- Benjamin Schwartz - Clinical Instructor of Medicine, Department of Surgery, Columbia University; Staff Cartoonist, The New Yorker
- Josh Seidman - Senior Vice President, Avalere Health
- Joe Selby - Executive Director, Patient-Centered Outcomes Research Institute
- Todd Sherer - CEO, The Michael J. Fox Foundation for Parkinson's Research
- Susan Sheridan - Director, Patient Engagement, Patient-Centered Outcomes Research Institute
- Sara Shnider - Executive Director, Prize4Life
- Jeffrey Shuren - Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration
- Josh Sommer - Executive Director, Chordoma Foundation
- Murray Stewart - Chief Medical Officer, Pharmaceuticals, GSK
- Rudolph Tanzi - Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Vice Chair, Neurology Research, Massachusetts General Hospital
- Gillian Tett - U.S. Managing Editor and Columnist, Financial Times
- Luke Timmerman - Founder & Editor, The Timmerman Report
- Mark Wagar - President, Heritage Medical Systems
- Jon White - Deputy National Coordinator, Office of the National Coordinator for Health Information Technology, U.S. Department of Health and Human Services
- Jedd Wolchok - Chief, Melanoma and Immunotherapeutics Service, and Lloyd J. Old and Virginia and Daniel K. Ludwig Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center
- Keith Yamamoto - Vice Chancellor for Research; Executive Vice Dean, School of Medicine; Professor, Cellular & Molecular Pharmacology, University of California, San Francisco
- David Zook - Chair, FaegreBD Consulting
